Alembic Pharmaceuticals gets EIR from USFDA for Oral Solid Formulation Facility

28 Sep 2024 Evaluate

Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at its Oral Solid Formulation Facility (F-I) at Panelav from July 17, 2024 to July 26, 2024. With this, for all the company’s USFDA facilities, EIRs are in place.   

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Alembic Pharma Share Price

855.20 -2.05 (-0.24%)
26-Dec-2025 09:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.20
Dr. Reddys Lab 1272.05
Cipla 1501.00
Zydus Lifesciences 917.55
Lupin 2106.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×